Nuntius Therapeutics
Mark Wolters is a seasoned professional in the biopharmaceutical industry, currently serving as the Business Development Lead at Nuntius Therapeutics. Previously, Mark has contributed as a member of the Scientific Advisory Board at Home Biosciences and worked as an Independent Business Development Executive. Additional roles include serving as a Transaction Advisor for Zumutor Biologics and as a Business Development and Transaction Advisor for Memo Therapeutics AG. Mark's academic background includes a postdoctoral fellowship in the Laboratory of Molecular Structure at the Massachusetts Institute of Technology and an education at Duke University's Fuqua School of Business from 2004 to 2005.
This person is not in any teams
This person is not in any offices
Nuntius Therapeutics
Nuntius Therapeutics are overcoming the biggest challenge for DNA, RNA, and CRISPR therapies: Delivering large genetic payloads into the correct cells. Their pipeline includes therapies for currently incurable rare diseases.